Skip to main content

Drug Therapy Guidelines Updates July 2020

Date:
July 24, 2020

New drug therapy guidelines have been developed with the guidance of our Pharmacy and Therapeutics Committee. These guidelines will be posted by August 1 and will be effective September 1. The following medications will require preauthorization:

  • Abraxane
  • Ergot Alkaloids*
  • Sitavig*
  • Tolsura*
  • Xiaflex*

Recent Articles

  • Pandemic Makes Early, Widespread Flu Vaccinations a Necessity
    As the COVID-19 pandemic continues, the Centers for Disease Control and Prevention (CDC) are encouraging early and widespread flu vaccinations. Health care professionals play a critical role in helping to ensure their patients get vaccinated. In this article, we provide updated CDC flu recommendations and resources, and offer comprehensive 2020-2021 flu vaccine information.
  • Wellframe for Behavioral Health and Beyond
    It’s important for patients to have behavioral health support when navigating stress caused by the pandemic. Wellframe is a digital care management solution that connects patients directly to a nurse, care manager, or health coach. This resource, offered by BlueShield, can help your patients achieve better health outcomes with programs for behavioral health issues and over a dozen other health conditions.
  • Suboxone to be Paid Fee-For-Service for BestPractice
    Medication-assisted treatment (MAT) with Suboxone will now be paid as fee-for-service for BestPractice providers.
  • Clinical Editing for Modifier 78
    Starting December 1, use of Modifier 78 will be processed through our clinical editor, instead of being adjusted on a post-payment basis. This will allow claims to process correctly. Here, we offer more information on Modifier 78.
  • Updated Provider Inquiry Form
    We have updated our Provider Inquiry form to ensure these forms are processed in an efficient and timely manner. Here, you can access the new form and learn more about the provider inquiry process.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information